Structure

Physi-Chem Properties

Molecular Weight:  196.04
Volume:  186.433
LogP:  2.448
LogD:  0.862
LogS:  -2.706
# Rotatable Bonds:  2
TPSA:  94.83
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  1
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.611
Synthetic Accessibility Score:  2.59
Fsp3:  0.111
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.657
MDCK Permeability:  3.2456807730341097e-06
Pgp-inhibitor:  0.0
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.028
20% Bioavailability (F20%):  0.422
30% Bioavailability (F30%):  0.936

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.047
Plasma Protein Binding (PPB):  89.76106262207031%
Volume Distribution (VD):  0.501
Pgp-substrate:  7.208649158477783%

ADMET: Metabolism

CYP1A2-inhibitor:  0.08
CYP1A2-substrate:  0.072
CYP2C19-inhibitor:  0.034
CYP2C19-substrate:  0.049
CYP2C9-inhibitor:  0.068
CYP2C9-substrate:  0.092
CYP2D6-inhibitor:  0.016
CYP2D6-substrate:  0.129
CYP3A4-inhibitor:  0.051
CYP3A4-substrate:  0.039

ADMET: Excretion

Clearance (CL):  1.726
Half-life (T1/2):  0.899

ADMET: Toxicity

hERG Blockers:  0.007
Human Hepatotoxicity (H-HT):  0.137
Drug-inuced Liver Injury (DILI):  0.721
AMES Toxicity:  0.035
Rat Oral Acute Toxicity:  0.031
Maximum Recommended Daily Dose:  0.024
Skin Sensitization:  0.721
Carcinogencity:  0.03
Eye Corrosion:  0.051
Eye Irritation:  0.933
Respiratory Toxicity:  0.965

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC278375

Natural Product ID:  NPC278375
Common Name*:   Haematommic Acid
IUPAC Name:   3-formyl-2,4-dihydroxy-6-methylbenzoic acid
Synonyms:  
Standard InCHIKey:  KCOOTJRKKIDHTM-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C9H8O5/c1-4-2-6(11)5(3-10)8(12)7(4)9(13)14/h2-3,11-12H,1H3,(H,13,14)/p-1
SMILES:  Cc1cc(c(C=O)c(c1C(=O)O)O)[O-]
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1315277
PubChem CID:   6710680
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0000176] Benzoic acids and derivatives
          • [CHEMONTID:0001248] Hydroxybenzoic acid derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11504 Lethariella cladonioides Species Parmeliaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11504 Lethariella cladonioides Species Parmeliaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO11504 Lethariella cladonioides Species Parmeliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT51 Individual Protein Microtubule-associated protein tau Homo sapiens Potency = 19952.6 nM PMID[473245]
NPT109 Individual Protein Cytochrome P450 3A4 Homo sapiens Potency = 25118.9 nM PMID[473245]
NPT73 Individual Protein Solute carrier organic anion transporter family member 1B1 Homo sapiens Inhibition = 54.98 % PMID[473246]
NPT72 Individual Protein Solute carrier organic anion transporter family member 1B3 Homo sapiens Inhibition = 81.5 % PMID[473246]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC278375 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9624 High Similarity NPC99441
0.9615 High Similarity NPC474519
0.9609 High Similarity NPC62219
0.9552 High Similarity NPC37530
0.9538 High Similarity NPC48036
0.9389 High Similarity NPC37299
0.9389 High Similarity NPC180261
0.9323 High Similarity NPC158481
0.9318 High Similarity NPC474394
0.9259 High Similarity NPC162939
0.9248 High Similarity NPC290803
0.9219 High Similarity NPC262671
0.9219 High Similarity NPC201728
0.9179 High Similarity NPC118919
0.9154 High Similarity NPC41263
0.9051 High Similarity NPC165172
0.9051 High Similarity NPC183345
0.9015 High Similarity NPC247477
0.9015 High Similarity NPC17840
0.8993 High Similarity NPC159721
0.8971 High Similarity NPC194579
0.8971 High Similarity NPC178467
0.8971 High Similarity NPC474771
0.8971 High Similarity NPC474849
0.8971 High Similarity NPC65837
0.8971 High Similarity NPC149372
0.8955 High Similarity NPC267205
0.8955 High Similarity NPC153783
0.8947 High Similarity NPC189823
0.8947 High Similarity NPC219892
0.8929 High Similarity NPC42540
0.8929 High Similarity NPC151607
0.8921 High Similarity NPC73061
0.8905 High Similarity NPC475974
0.8872 High Similarity NPC296158
0.8857 High Similarity NPC471731
0.8849 High Similarity NPC290550
0.8849 High Similarity NPC470842
0.8841 High Similarity NPC474655
0.8841 High Similarity NPC275356
0.8841 High Similarity NPC88269
0.8832 High Similarity NPC70380
0.8832 High Similarity NPC471452
0.8832 High Similarity NPC71256
0.8806 High Similarity NPC41847
0.8786 High Similarity NPC471733
0.8779 High Similarity NPC477454
0.8777 High Similarity NPC472601
0.8777 High Similarity NPC472600
0.8768 High Similarity NPC177307
0.8768 High Similarity NPC9121
0.8768 High Similarity NPC191835
0.8768 High Similarity NPC212693
0.8768 High Similarity NPC472403
0.8768 High Similarity NPC94248
0.8759 High Similarity NPC50455
0.8759 High Similarity NPC86524
0.8759 High Similarity NPC191976
0.8759 High Similarity NPC235115
0.8759 High Similarity NPC254847
0.875 High Similarity NPC294964
0.8741 High Similarity NPC166583
0.8741 High Similarity NPC53362
0.8714 High Similarity NPC313123
0.8714 High Similarity NPC472603
0.8714 High Similarity NPC472604
0.8714 High Similarity NPC204045
0.8714 High Similarity NPC478217
0.8714 High Similarity NPC305845
0.8714 High Similarity NPC187843
0.8714 High Similarity NPC472605
0.8712 High Similarity NPC473691
0.8707 High Similarity NPC89625
0.8707 High Similarity NPC149618
0.8705 High Similarity NPC139634
0.8705 High Similarity NPC105456
0.8705 High Similarity NPC92655
0.8705 High Similarity NPC190457
0.8696 High Similarity NPC53206
0.8696 High Similarity NPC135837
0.8696 High Similarity NPC471905
0.8696 High Similarity NPC245058
0.8696 High Similarity NPC53414
0.8686 High Similarity NPC161632
0.8686 High Similarity NPC182496
0.8686 High Similarity NPC180905
0.8671 High Similarity NPC163846
0.8671 High Similarity NPC225173
0.8652 High Similarity NPC82913
0.8652 High Similarity NPC474961
0.8652 High Similarity NPC135524
0.8643 High Similarity NPC168471
0.8633 High Similarity NPC33144
0.8633 High Similarity NPC221104
0.8633 High Similarity NPC478200
0.8633 High Similarity NPC472602
0.8623 High Similarity NPC291454
0.8623 High Similarity NPC223836
0.8615 High Similarity NPC215392
0.8615 High Similarity NPC226275
0.8613 High Similarity NPC175943
0.8613 High Similarity NPC166480
0.8613 High Similarity NPC282780
0.8611 High Similarity NPC125801
0.8611 High Similarity NPC471734
0.8601 High Similarity NPC473692
0.8593 High Similarity NPC147757
0.8592 High Similarity NPC478202
0.8592 High Similarity NPC472610
0.8592 High Similarity NPC354984
0.8582 High Similarity NPC1704
0.8582 High Similarity NPC472035
0.8582 High Similarity NPC110810
0.8582 High Similarity NPC67650
0.8582 High Similarity NPC478201
0.8582 High Similarity NPC53649
0.8571 High Similarity NPC268052
0.8571 High Similarity NPC242994
0.8571 High Similarity NPC138099
0.8571 High Similarity NPC52358
0.8571 High Similarity NPC32360
0.8571 High Similarity NPC143438
0.8562 High Similarity NPC119929
0.855 High Similarity NPC91105
0.855 High Similarity NPC218333
0.8542 High Similarity NPC471735
0.8542 High Similarity NPC473023
0.8538 High Similarity NPC146642
0.8531 High Similarity NPC21599
0.8531 High Similarity NPC244691
0.8531 High Similarity NPC193703
0.8531 High Similarity NPC471906
0.8531 High Similarity NPC48762
0.8529 High Similarity NPC275504
0.8521 High Similarity NPC182255
0.8521 High Similarity NPC193555
0.8521 High Similarity NPC94076
0.8519 High Similarity NPC92624
0.8519 High Similarity NPC476119
0.8516 High Similarity NPC230349
0.8511 High Similarity NPC181560
0.8511 High Similarity NPC155205
0.8511 High Similarity NPC169452
0.8511 High Similarity NPC158472
0.8507 High Similarity NPC209959
0.8503 High Similarity NPC133856
0.85 High Similarity NPC4214
0.8496 Intermediate Similarity NPC475733
0.8493 Intermediate Similarity NPC291049
0.8493 Intermediate Similarity NPC233267
0.8489 Intermediate Similarity NPC156967
0.8489 Intermediate Similarity NPC472599
0.8485 Intermediate Similarity NPC306288
0.8485 Intermediate Similarity NPC472029
0.8485 Intermediate Similarity NPC65761
0.8478 Intermediate Similarity NPC44437
0.8478 Intermediate Similarity NPC475645
0.8477 Intermediate Similarity NPC143050
0.8472 Intermediate Similarity NPC75694
0.8472 Intermediate Similarity NPC34482
0.8467 Intermediate Similarity NPC478190
0.8462 Intermediate Similarity NPC84266
0.8462 Intermediate Similarity NPC469542
0.8462 Intermediate Similarity NPC294037
0.8462 Intermediate Similarity NPC51106
0.8462 Intermediate Similarity NPC472006
0.8456 Intermediate Similarity NPC259942
0.8451 Intermediate Similarity NPC244923
0.8451 Intermediate Similarity NPC246638
0.8451 Intermediate Similarity NPC90411
0.8451 Intermediate Similarity NPC158634
0.8451 Intermediate Similarity NPC149533
0.8451 Intermediate Similarity NPC475730
0.845 Intermediate Similarity NPC209486
0.845 Intermediate Similarity NPC40649
0.8446 Intermediate Similarity NPC271681
0.8446 Intermediate Similarity NPC273483
0.8444 Intermediate Similarity NPC95537
0.844 Intermediate Similarity NPC247409
0.844 Intermediate Similarity NPC471819
0.8433 Intermediate Similarity NPC160499
0.8429 Intermediate Similarity NPC53001
0.8425 Intermediate Similarity NPC37139
0.8425 Intermediate Similarity NPC471907
0.8425 Intermediate Similarity NPC105415
0.8417 Intermediate Similarity NPC475917
0.8414 Intermediate Similarity NPC470570
0.8409 Intermediate Similarity NPC283514
0.8409 Intermediate Similarity NPC309765
0.8403 Intermediate Similarity NPC210966
0.8403 Intermediate Similarity NPC126882
0.8403 Intermediate Similarity NPC478203
0.8397 Intermediate Similarity NPC149246
0.8394 Intermediate Similarity NPC85342
0.8392 Intermediate Similarity NPC250755
0.8392 Intermediate Similarity NPC322112
0.8392 Intermediate Similarity NPC474385
0.8389 Intermediate Similarity NPC208806
0.8389 Intermediate Similarity NPC472799
0.8389 Intermediate Similarity NPC470102

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC278375 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8759 High Similarity NPD1509 Clinical (unspecified phase)
0.8472 Intermediate Similarity NPD2533 Approved
0.8472 Intermediate Similarity NPD2532 Approved
0.8472 Intermediate Similarity NPD2534 Approved
0.844 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8276 Intermediate Similarity NPD7390 Discontinued
0.8169 Intermediate Similarity NPD5405 Approved
0.8169 Intermediate Similarity NPD5404 Approved
0.8169 Intermediate Similarity NPD5408 Approved
0.8169 Intermediate Similarity NPD5406 Approved
0.7972 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7943 Intermediate Similarity NPD943 Approved
0.7926 Intermediate Similarity NPD1201 Approved
0.7908 Intermediate Similarity NPD7819 Suspended
0.7898 Intermediate Similarity NPD6232 Discontinued
0.7832 Intermediate Similarity NPD1607 Approved
0.7826 Intermediate Similarity NPD1470 Approved
0.7826 Intermediate Similarity NPD1164 Approved
0.7793 Intermediate Similarity NPD1551 Phase 2
0.7762 Intermediate Similarity NPD230 Phase 1
0.775 Intermediate Similarity NPD7473 Discontinued
0.7737 Intermediate Similarity NPD9269 Phase 2
0.7733 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7724 Intermediate Similarity NPD1510 Phase 2
0.7704 Intermediate Similarity NPD9268 Approved
0.7692 Intermediate Similarity NPD1240 Approved
0.7673 Intermediate Similarity NPD5711 Approved
0.7673 Intermediate Similarity NPD5710 Approved
0.7671 Intermediate Similarity NPD2935 Discontinued
0.7612 Intermediate Similarity NPD9493 Approved
0.761 Intermediate Similarity NPD6959 Discontinued
0.7548 Intermediate Similarity NPD7411 Suspended
0.7538 Intermediate Similarity NPD74 Approved
0.7538 Intermediate Similarity NPD9266 Approved
0.75 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD9545 Approved
0.7481 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7462 Intermediate Similarity NPD9263 Approved
0.7462 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7462 Intermediate Similarity NPD9264 Approved
0.7462 Intermediate Similarity NPD9267 Approved
0.7452 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD1549 Phase 2
0.7421 Intermediate Similarity NPD7075 Discontinued
0.7419 Intermediate Similarity NPD3226 Approved
0.7405 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD920 Approved
0.7372 Intermediate Similarity NPD6599 Discontinued
0.7368 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD7768 Phase 2
0.7351 Intermediate Similarity NPD3750 Approved
0.7351 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD5844 Phase 1
0.7319 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD1243 Approved
0.7285 Intermediate Similarity NPD2800 Approved
0.7278 Intermediate Similarity NPD1934 Approved
0.7273 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD919 Approved
0.7267 Intermediate Similarity NPD2346 Discontinued
0.7266 Intermediate Similarity NPD4626 Approved
0.7261 Intermediate Similarity NPD4380 Phase 2
0.7254 Intermediate Similarity NPD1283 Approved
0.7237 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.723 Intermediate Similarity NPD6651 Approved
0.7218 Intermediate Similarity NPD4750 Phase 3
0.7208 Intermediate Similarity NPD1511 Approved
0.7208 Intermediate Similarity NPD6799 Approved
0.7206 Intermediate Similarity NPD9281 Approved
0.7205 Intermediate Similarity NPD3749 Approved
0.7202 Intermediate Similarity NPD6559 Discontinued
0.7192 Intermediate Similarity NPD411 Approved
0.7171 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD6801 Discontinued
0.7161 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7154 Intermediate Similarity NPD9261 Approved
0.7115 Intermediate Similarity NPD1512 Approved
0.7113 Intermediate Similarity NPD9717 Approved
0.7086 Intermediate Similarity NPD2796 Approved
0.7081 Intermediate Similarity NPD3817 Phase 2
0.7077 Intermediate Similarity NPD846 Approved
0.7077 Intermediate Similarity NPD940 Approved
0.7075 Intermediate Similarity NPD3764 Approved
0.7075 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD5691 Approved
0.7042 Intermediate Similarity NPD1281 Approved
0.7037 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD3882 Suspended
0.702 Intermediate Similarity NPD2799 Discontinued
0.702 Intermediate Similarity NPD3748 Approved
0.7019 Intermediate Similarity NPD2801 Approved
0.7019 Intermediate Similarity NPD1465 Phase 2
0.7013 Intermediate Similarity NPD4628 Phase 3
0.7013 Intermediate Similarity NPD7003 Approved
0.6981 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6974 Remote Similarity NPD6100 Approved
0.6974 Remote Similarity NPD6099 Approved
0.697 Remote Similarity NPD1247 Approved
0.6966 Remote Similarity NPD1203 Approved
0.6959 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6941 Remote Similarity NPD5953 Discontinued
0.6933 Remote Similarity NPD447 Suspended
0.6932 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6923 Remote Similarity NPD3300 Phase 2
0.6923 Remote Similarity NPD6020 Phase 2
0.6913 Remote Similarity NPD520 Approved
0.6913 Remote Similarity NPD6663 Approved
0.6901 Remote Similarity NPD3019 Approved
0.6901 Remote Similarity NPD2932 Approved
0.6897 Remote Similarity NPD8150 Discontinued
0.689 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7458 Discontinued
0.6871 Remote Similarity NPD9494 Approved
0.6871 Remote Similarity NPD5736 Approved
0.6852 Remote Similarity NPD37 Approved
0.6845 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6845 Remote Similarity NPD6166 Phase 2
0.6845 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6835 Remote Similarity NPD5951 Approved
0.6824 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6824 Remote Similarity NPD7286 Phase 2
0.6807 Remote Similarity NPD5494 Approved
0.6806 Remote Similarity NPD422 Phase 1
0.6797 Remote Similarity NPD3299 Clinical (unspecified phase)
0.6795 Remote Similarity NPD3400 Discontinued
0.6784 Remote Similarity NPD7074 Phase 3
0.6769 Remote Similarity NPD288 Approved
0.6765 Remote Similarity NPD3818 Discontinued
0.6759 Remote Similarity NPD1608 Approved
0.6755 Remote Similarity NPD2979 Phase 3
0.6747 Remote Similarity NPD6234 Discontinued
0.6742 Remote Similarity NPD1242 Phase 1
0.6733 Remote Similarity NPD2313 Discontinued
0.6731 Remote Similarity NPD2654 Approved
0.673 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6727 Remote Similarity NPD4966 Approved
0.6727 Remote Similarity NPD4965 Approved
0.6727 Remote Similarity NPD4967 Phase 2
0.6726 Remote Similarity NPD7229 Phase 3
0.6725 Remote Similarity NPD7054 Approved
0.6723 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6713 Remote Similarity NPD1651 Approved
0.6711 Remote Similarity NPD6832 Phase 2
0.6711 Remote Similarity NPD1899 Clinical (unspecified phase)
0.671 Remote Similarity NPD2344 Approved
0.6692 Remote Similarity NPD844 Approved
0.6689 Remote Similarity NPD1019 Discontinued
0.6689 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6688 Remote Similarity NPD4308 Phase 3
0.6688 Remote Similarity NPD8166 Discontinued
0.6686 Remote Similarity NPD7472 Approved
0.6667 Remote Similarity NPD4625 Phase 3
0.6667 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7177 Discontinued
0.6667 Remote Similarity NPD5402 Approved
0.6667 Remote Similarity NPD1778 Approved
0.6667 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6649 Remote Similarity NPD8151 Discontinued
0.6647 Remote Similarity NPD6797 Phase 2
0.6646 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6646 Remote Similarity NPD5403 Approved
0.6645 Remote Similarity NPD4060 Phase 1
0.6645 Remote Similarity NPD2438 Suspended
0.6642 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6629 Remote Similarity NPD8312 Approved
0.6629 Remote Similarity NPD8313 Approved
0.6625 Remote Similarity NPD5401 Approved
0.6623 Remote Similarity NPD3268 Approved
0.6609 Remote Similarity NPD7251 Discontinued
0.6603 Remote Similarity NPD1471 Phase 3
0.6603 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6584 Remote Similarity NPD6273 Approved
0.6577 Remote Similarity NPD2798 Approved
0.6576 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6575 Remote Similarity NPD6535 Approved
0.6575 Remote Similarity NPD6534 Approved
0.6571 Remote Similarity NPD7635 Approved
0.6571 Remote Similarity NPD7808 Phase 3
0.6569 Remote Similarity NPD2342 Discontinued
0.6568 Remote Similarity NPD7199 Phase 2
0.6566 Remote Similarity NPD4288 Approved
0.6565 Remote Similarity NPD1809 Phase 2
0.6559 Remote Similarity NPD7435 Discontinued
0.6556 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6552 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6552 Remote Similarity NPD17 Approved
0.6552 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6549 Remote Similarity NPD255 Approved
0.6549 Remote Similarity NPD256 Approved
0.6541 Remote Similarity NPD6190 Approved
0.6541 Remote Similarity NPD2309 Approved
0.6538 Remote Similarity NPD4476 Approved
0.6538 Remote Similarity NPD2531 Phase 2
0.6538 Remote Similarity NPD9570 Approved
0.6538 Remote Similarity NPD4477 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data